Journal article

HealthMap: a cluster randomised trial of interactive health plans and self-management support to prevent coronary heart disease in people with HIV

S Dodson, KM Klassen, K McDonald, T Millard, RH Osborne, MW Battersby, CK Fairley, J Simpson, P Lorgelly, A Tonkin, J Roney, S Slavin, J Sterjovski, M Brereton, SR Lewin, L Crooks, J Watson, MR Kidd, I Williams, JH Elliott

BMC Infectious Diseases | BioMed Central | Published : 2016

Abstract

Background: The leading causes of morbidity and mortality for people in high-income countries living with HIV are now non-AIDS malignancies, cardiovascular disease and other non-communicable diseases associated with ageing. This protocol describes the trial of HealthMap, a model of care for people with HIV (PWHIV) that includes use of an interactive shared health record and self-management support. The aims of the HealthMap trial are to evaluate engagement of PWHIV and healthcare providers with the model, and its effectiveness for reducing coronary heart disease risk, enhancing self-management, and improving mental health and quality of life of PWHIV. Methods/Design: The study is a two-arm ..

View full abstract

Grants

Awarded by National Health and Medical Research Council (NHMRC)


Awarded by NHMRC Senior Research Fellowship


Funding Acknowledgements

This research is supported by the National Health and Medical Research Council (NHMRC; Partnership Project Grant APP 1012459), the Alfred Foundation, Monash University, Deakin University, Flinders University, Queensland University of Technology, National Association of People with HIV Australia (NAPWHA), Australasia Society for HIV Medicine (ASHM), Viral Hepatitis and Sexual Health Medicine, and Living Positive Victoria. Richard Osbome is supported by a NHMRC Senior Research Fellowship (#1059122). The authors would also like to acknowledge the significant contribution of the HealthMap Associate Investigators: Mukesh Haikerwal, Bruce Hollingsworth, Jennifer Hoy, James McMahon, John McNeil, Richard Moore, Jeffrey Post, Norman Roth, Marlene Velecky, Olga Vujovic and Andrew Way. We also thank all those involved in the development of the intervention, including: Julia Stout and Andrea Morrow for supporting the operational aspects of the trial; Jarrel Seah, Alex Tam and Unisolve Pty Ltd for development and work on the platform components of the intervention; and Ron Borland of Cancer Council Victoria, for smoking outcome evaluation advice.